1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina C.; Bajaj, Anshika; Archer, Jacob F.; Reeves, Rebecca S.; Ngo, Lisa Y.; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fu... Journal: Journal for immunotherapy of cancer Issue: Volume 4(2016)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Phase I Study of FOLFIRINOX Plus IPI-926, a Hedgehog Pathway Inhibitor, for Advanced Pancreatic Adenocarcinoma. Issue 3 (March 2016) Authors: Ko, Andrew H.; LoConte, Noelle; Tempero, Margaret A.; Walker, Evan J.; Kate Kelley, R.; Lewis, Stephanie; Chang, Wei-Chou; Kantoff, Emily; Vannier, Michael W.; Catenacci, Daniel V.; Venook, Alan P.; Kindler, Hedy L. Journal: Pancreas Issue: Volume 45:Issue 3(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A UGT1A1 genotype‐guided dosing study of modified FOLFIRINOX in previously untreated patients with advanced gastrointestinal malignancies. Issue 10 (15th January 2019) Authors: Sharma, Manish R.; Joshi, Smita S.; Karrison, Theodore G.; Allen, Kenisha; Suh, Grace; Marsh, Robert; Kozloff, Mark F.; Polite, Blase N.; Catenacci, Daniel V. T.; Kindler, Hedy L. Journal: Cancer Issue: Volume 125:Issue 10(2019) Page Start: 1629 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. An initial genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients in CALGB 80303 (Alliance). Issue 6 (August 2019) Authors: Innocenti, Federico; Jiang, Chen; Sibley, Alexander B.; Denning, Stefanie; Etheridge, Amy S.; Watson, Dorothy; Niedzwiecki, Donna; Hatch, Ace J.; Hurwitz, Herbert I.; Nixon, Andrew B.; Furukawa, Yoichi; Kubo, Michiaki; Crona, Daniel J.; Kindler, Hedy L.; McLeod, Howard L.; Ratain, Mark J.; Owzar,... Journal: Pharmaocogenetics and genomics Issue: Volume 29:Issue 6(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Focal adhesion kinase a potential therapeutic target for pancreatic cancer and malignant pleural mesothelioma. Issue 4 (3rd April 2018) Authors: Kanteti, Rajani; Mirzapoiazova, Tamara; Riehm, Jacob J.; Dhanasingh, Immanuel; Mambetsariev, Bolot; Wang, Jiale; Kulkarni, Prakash; Kaushik, Garima; Seshacharyulu, Parthasarathy; Ponnusamy, Moorthy P.; Kindler, Hedy L.; Nasser, Mohd W.; Batra, Surinder K.; Salgia, Ravi Journal: Cancer biology & therapy Issue: Volume 19:Issue 4(2018) Page Start: 316 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Genome‐wide association studies of survival in 1520 cancer patients treated with bevacizumab‐containing regimens. Issue 2 (5th October 2021) Authors: Quintanilha, Julia C. F.; Wang, Jin; Sibley, Alexander B.; Xu, Wei; Espin‐Garcia, Osvaldo; Jiang, Chen; Etheridge, Amy S.; Ratain, Mark J.; Lenz, Heinz‐Josef; Bertagnolli, Monica; Kindler, Hedy L.; Dickler, Maura N.; Venook, Alan; Liu, Geoffrey; Owzar, Kouros; Lin, Danyu; Innocenti, Federico Journal: International journal of cancer Issue: Volume 150:Issue 2(2022) Page Start: 279 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer. Issue 34 (1st December 2022) Authors: Kindler, Hedy L.; Hammel, Pascal; Reni, Michele; Van Cutsem, Eric; Macarulla, Teresa; Hall, Michael J.; Park, Joon Oh; Hochhauser, Daniel; Arnold, Dirk; Oh, Do-Youn; Reinacher-Schick, Anke; Tortora, Giampaolo; Algül, Hana; O'Reilly, Eileen M.; Bordia, Sonal; McGuinness, David; Cui, Karen; Locker,... Journal: Journal of clinical oncology Issue: Volume 40:Issue 34(2022) Page Start: 3929 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Patient‐centered outcomes in the POLO study of active maintenance olaparib for germline BRCA‐mutated metastatic pancreatic cancer. Issue 9 (22nd February 2023) Authors: Kindler, Hedy L.; Yoo, Hyun Kyoo; Hettle, Robert; Cui, Karen Y.; Joo, Seongjung; Locker, Gershon Y.; Golan, Talia Journal: Cancer Issue: Volume 129:Issue 9(2023) Page Start: 1411 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild‐type BRCA pancreatic ductal adenocarcinoma. Issue 7 (16th January 2018) Authors: O'Reilly, Eileen M.; Lee, Jonathan W.; Lowery, Maeve A.; Capanu, Marinela; Stadler, Zsofia K.; Moore, Malcolm J.; Dhani, Neesha; Kindler, Hedy L.; Estrella, Hayley; Maynard, Hannah; Golan, Talia; Segal, Amiel; Salo‐Mullen, Erin E.; Yu, Kenneth H.; Epstein, Andrew S.; Segal, Michal; Brenner, Robin... Journal: Cancer Issue: Volume 124:Issue 7(2018) Page Start: 1374 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinoma. (January 2018) Authors: Lowery, Maeve A.; Kelsen, David P.; Capanu, Marinela; Smith, Sloane C.; Lee, Jonathan W.; Stadler, Zsofia K.; Moore, Malcolm J.; Kindler, Hedy L.; Golan, Talia; Segal, Amiel; Maynard, Hannah; Hollywood, Ellen; Moynahan, MaryEllen; Salo-Mullen, Erin E.; Do, Richard Kinh Gian; Chen, Alice P.; Yu, K... Journal: European journal of cancer Issue: Volume 89(2018) Page Start: 19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗